Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for ...

MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025SAN DIEGO, Nov. 02, 2025 (GLOBE ...